Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF U.S. LUNG CANCER SCREENING SOFTWARE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE U.S. LUNG CANCER SCREENING SOFTWARE MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMEOLOGY
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 U.S. LUNG CANCER SCREENING SOFTWARE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PORTERS FIVE FORCES
5.2 REGULATORY STANDARDS
5.3 TECHNOLOGICAL TRENDS
5.4 VALUE CHAIN ANALYSIS
5.5 COMPANY COMPARITIVE ANALYSIS
5.6 KEY STRATEGIC INITIATIVES
5.7 PRICING ANALYSIS
6 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY OFFERING
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 STANDALONE
6.2.2 INTEGRATED
6.3 SERVICES
6.3.1 CONSULTING
6.3.2 INTEGRATION AND IMPLEMENTATION
6.3.3 SUPPORT AND MAINTENANCE
7 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 PATHOLOGY AND CANCER STAGING
7.3 PATIENT TRACKING
7.4 STATISTICAL AUDIT REPORTING
7.5 DATA MINING AND ANALYTICS
7.6 PATIENT COORDINATION AND WORKFLOW
7.7 PROVIDER ENGAGEMENT
7.8 INCIDENTAL NODULE MANAGER
7.9 COMMUNICATION
7.1 OTHERS
8 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY DEPLOYMENT MODEL
8.1 OVERVIEW
8.2 ON-PREMISE
8.3 CLOUD
9 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY ORGANIZATION SIZE
9.1 OVERVIEW
9.2 SMALL AND MEDIUM SIZED ENTERPRISES (SMES)
9.2.1 BY DEPLOYMENT MODEL
9.2.1.1. CLOUD
9.2.1.2. ON PREMISES
9.3 LARGE ENTERPRISE
9.3.1 BY DEPLOYMENT MODEL
9.3.1.1. CLOUD
9.3.1.2. ON PREMISES
10 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY INDICATION
10.1 OVERVIEW
10.2 SMALL CELL LUNG CANCER (SCLC)
10.3 NON-SMALL CELL LUNG CANCER (NSCLC)
11 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY TECHNIQUE
11.1 OVERVIEW
11.2 LOW DOSE COMPUTED TOMOGRAPHY (LDCT)
11.3 CHEST RADIOGRAPHY & SPUTUM CYTOLOGY
12 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE
12.1 OVERVIEW
12.2 INDIVIDUAL
12.3 INSTITUTIONAL
13 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.2.1 BY APPLICATION
13.2.1.1. PATHOLOGY AND CANCER STAGING
13.2.1.2. PATIENT TRACKING
13.2.1.3. STATISTICAL AUDIT REPORTING
13.2.1.4. DATA MINING AND ANALYTICS
13.2.1.5. PATIENT COORDINATION AND WORKFLOW
13.2.1.6. PROVIDER ENGAGEMENT
13.2.1.7. INCIDENTAL NODULE MANAGER
13.2.1.8. COMMUNICATION
13.2.1.9. LUNG CANCER SCREENING PROGRAM
13.2.1.10. OTHERS
13.3 CLINICS
13.3.1 BY APPLICATION
13.3.1.1. PATHOLOGY AND CANCER STAGING
13.3.1.2. PATIENT TRACKING
13.3.1.3. STATISTICAL AUDIT REPORTING
13.3.1.4. DATA MINING AND ANALYTICS
13.3.1.5. PATIENT COORDINATION AND WORKFLOW
13.3.1.6. PROVIDER ENGAGEMENT
13.3.1.7. INCIDENTAL NODULE MANAGER
13.3.1.8. COMMUNICATION
13.3.1.9. LUNG CANCER SCREENING PROGRAM
13.3.1.10. OTHERS
13.4 ONCLOGY CENTERS
13.4.1 BY APPLICATION
13.4.1.1. PATHOLOGY AND CANCER STAGING
13.4.1.2. PATIENT TRACKING
13.4.1.3. STATISTICAL AUDIT REPORTING
13.4.1.4. DATA MINING AND ANALYTICS
13.4.1.5. PATIENT COORDINATION AND WORKFLOW
13.4.1.6. PROVIDER ENGAGEMENT
13.4.1.7. INCIDENTAL NODULE MANAGER
13.4.1.8. COMMUNICATION
13.4.1.9. LUNG CANCER SCREENING PROGRAM
13.4.1.10. OTHERS
13.5 AMBULATORY SURGICAL CENTERS
13.5.1 BY APPLICATION
13.5.1.1. PATHOLOGY AND CANCER STAGING
13.5.1.2. PATIENT TRACKING
13.5.1.3. STATISTICAL AUDIT REPORTING
13.5.1.4. DATA MINING AND ANALYTICS
13.5.1.5. PATIENT COORDINATION AND WORKFLOW
13.5.1.6. PROVIDER ENGAGEMENT
13.5.1.7. INCIDENTAL NODULE MANAGER
13.5.1.8. COMMUNICATION
13.5.1.9. LUNG CANCER SCREENING PROGRAM
13.5.1.10. OTHERS
13.6 OTHERS
14 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: U.S.
14.2 MERGERS & ACQUISITIONS
14.3 NEW PRODUCT DEVELOPMENT & APPROVALS
14.4 EXPANSIONS
14.5 REGULATORY CHANGES
14.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
15 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, SWOT AND DBMR ANALYSIS
16 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, COMPANY PROFILE
16.1 INTELERAD
16.1.1 COMPANY OVERVIEW
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPEMENTS
16.2 LUNGVIEW
16.2.1 COMPANY OVERVIEW
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPEMENTS
16.3 MAGVIEW
16.3.1 COMPANY OVERVIEW
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPEMENTS
16.4 KONINKLIJKE PHILIPS N.V
16.4.1 COMPANY OVERVIEW
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 VOLPARA HEALTH LIMITED
16.5.1 COMPANY OVERVIEW
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPEMENTS
16.6 THYNK HEALTH
16.6.1 COMPANY OVERVIEW
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPEMENTS
16.7 NUANCE COMMUNICATIONS, INC
16.7.1 COMPANY OVERVIEW
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPEMENTS
16.8 SIEMENS HEALTHCARE GMBH
16.8.1 COMPANY OVERVIEW
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPEMENTS
16.9 EON
16.9.1 COMPANY OVERVIEW
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPEMENTS
16.1 MEDTRONIC
16.10.1 COMPANY OVERVIEW
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPEMENTS
16.11 GE HEALTHCARE
16.11.1 COMPANY OVERVIEW
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPEMENTS
16.12 VIDA DIAGNOSTICS INC.
16.12.1 COMPANY OVERVIEW
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPEMENTS
16.13 OPTELLUM LTD
16.13.1 COMPANY OVERVIEW
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPEMENTS
16.14 HEALTHMYNE
16.14.1 COMPANY OVERVIEW
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPEMENTS
16.15 RIVERAIN TECHNOLOGIES
16.15.1 COMPANY OVERVIEW
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPEMENTS
16.16 AGAMON
16.16.1 COMPANY OVERVIEW
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPEMENTS
17 RELATED REPORTS
18 QUESTIONNAIRE
19 CONCLUSION
20 ABOUT DATA BRIDGE MARKET RESEARCH
